Table 3.
Patient and programmatic factors influencing second viral load uptake and result in six MSF-supported health centers in Maputo. Mozambique, between 2014 and 2015
| Follow-up viral load uptake | Patients with 2nd viral load done | |||||||
|---|---|---|---|---|---|---|---|---|
| Eligible follow-up VLa | With follow-up VL (%) | aOR (95% CI) | p aOR: adjusted Odds Ratio p value | With follow-up VL | Follow-up VL≥3000 (%) | aOR (95% CI) | p value | |
| Total | 3100 | 1095 (35) | NA (NA) | NA | 1095 | 678 (62) | NA (NA) | NA |
| Gender | NS | NS | ||||||
| Female | 1978 | 709 (36) | 1 (NA) | 709 | 428 (60) | 1 (NA) | ||
| Male | 1122 | 386 (34) | 0.82 (0.70–0.96) | 386 | 250 (65) | 1.15 (0.88–1.51) | ||
| Age category (years) | <0.001 | NS | ||||||
| < 5 | 102 | 32 (31) | 1.06 (0.68–1.65) | 32 | 17 (53) | 0.62 (0.30–1.29) | ||
| 5≤15 | 347 | 160 (46) | 1.46 (1.14–1.87) | 160 | 103 (64) | 0.95 (0.64–1.39) | ||
| 15≤25 | 203 | 85 (42) | 1.11 (0.78–1.59) | 85 | 59 (70) | 1.13 (0.63–2.00) | ||
| 25≤35 | 687 | 183 (27) | 0.70 (0.57–0.86) | 183 | 119 (65) | 1.38 (0.95–1.98) | ||
| >35 | 1761 | 635 (36) | 1 (NA) | 635 | 380 (60) | 1 (NA) | ||
| Year ART start | <0.001 | NS | ||||||
| < 2010 | 1009 | 406 (40) | 3.84 (2.71–5.42) | 406 | 247 (61) | 1.13 (0.60–2.11) | ||
| 2010–2013 | 1751 | 641 (37) | 3.59 (2.57–5.00) | 641 | 403 (63) | 1.22 (0.66–2.25) | ||
| 2014-2015 | 340 | 48 (14) | 1 (NA) | 48 | 28 (58) | 1 (NA) | ||
| Service delivery | <0.001 | <0.001 | ||||||
| Conventionalb | 1930 | 622 (32) | 1 (NA) | 622 | 398 (64) | 1 (NA) | ||
| Conventionalb & iDART | 705 | 271 (38) | 1.32 (1.10–1.59) | 271 | 169 (62) | 0.92 (0.68–1.24) | ||
| CAG | 95 | 54 (57) | 2.67 (1.75–4.07) | 54 | 19 (35) | 0.30 (0.17–0.55) | ||
| SAAJ | 120 | 71 (59) | 2.66 (1.71–4.13) | 71 | 54 (76) | 1.74 (0.90–3.34) | ||
| ANC/PNC | 192 | 52 (27) | 1.05 (0.73–1.50) | 52 | 25 (48) | 0.46 (0.25–0.84) | ||
| TB | 58 | 25 (43) | 2.67 (1.50–4.73) | 25 | 13 (52) | 0.59 (0.26–1.34) | ||
a Eligible for a follow-up VL testing included all patients on ART with a first VL above 3000 copies/ml, and who had done their first VL more than 2 months ago.
b Conventional care is the care provided to all patients not attending the other mentioned service delivery platforms.
aOR: adjusted odds ratio; ANC: antenatal care; ART: antiretroviral therapy; CAG: community ART Groups; iDART: intelligent dispensing of ART, pharmacy software to dispense and monitor ART; NA: not applicable; NS: not significant; PNC: postnatal care; SAAJ: Servicio Apoio Amigos Jovens (Adolescent Friendly service); VL: viral load.